TDOC vs. HIMS, AUNA, LFMD, AIRS, PTWO, SHLT, TOI, CANOQ, CCM, and LEGN
Should you be buying Teladoc Health stock or one of its competitors? The main competitors of Teladoc Health include Hims & Hers Health (HIMS), Auna (AUNA), LifeMD (LFMD), AirSculpt Technologies (AIRS), Pono Capital Two (PTWO), SHL Telemedicine (SHLT), Oncology Institute (TOI), Cano Health (CANOQ), Concord Medical Services (CCM), and Legend Biotech (LEGN).
Teladoc Health (NYSE:TDOC) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations, community ranking and media sentiment.
In the previous week, Teladoc Health had 2 more articles in the media than Hims & Hers Health. MarketBeat recorded 29 mentions for Teladoc Health and 27 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.47 beat Teladoc Health's score of 0.19 indicating that Hims & Hers Health is being referred to more favorably in the news media.
Teladoc Health received 641 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 63.35% of users gave Teladoc Health an outperform vote while only 34.57% of users gave Hims & Hers Health an outperform vote.
Teladoc Health currently has a consensus target price of $18.22, suggesting a potential upside of 70.99%. Hims & Hers Health has a consensus target price of $16.14, suggesting a potential downside of 25.32%. Given Teladoc Health's higher possible upside, equities research analysts clearly believe Teladoc Health is more favorable than Hims & Hers Health.
Hims & Hers Health has a net margin of -0.24% compared to Teladoc Health's net margin of -8.90%. Hims & Hers Health's return on equity of -0.70% beat Teladoc Health's return on equity.
Teladoc Health has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.
Hims & Hers Health has lower revenue, but higher earnings than Teladoc Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.
76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 1.0% of Teladoc Health shares are held by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Hims & Hers Health beats Teladoc Health on 11 of the 18 factors compared between the two stocks.
Get Teladoc Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TDOC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Teladoc Health Competitors List
Related Companies and Tools
